Business
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit
SAN DIEGO, February 04, 2026--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026, at 4:00 p.m. ET.
About this update from Travere Therapeutics, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1604,"height":352,"url":"https://media.zenfs.com/en/business-wire.com/0e95d43ec78825c46ab84f374dec279d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/PIVROQzYmmC8r_x7_Wbm0g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIxMTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0e95d43ec78825c46ab84f374dec279d","width":960,"height":211},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/wFj8OxwnzvdTIqzSxwJ0Zw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MjY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/0e95d43ec78825c46ab84f374dec279d","width":1200,"height":263}},"lazy":false},{"type":"text","content":"SAN DIEGO, February 04, 2026--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026, at 4:00 p.m. ET.","length":247,"tagName":"p"},{"type":"text","content":"A live webcast will be accessible on the Investor page of Travere’s website at ir.travere.com/events-and-presentations, and a replay will be available for up to 30 days following the event.","length":189,"tagName":"p"},{"type":"text","content":"About Travere Therapeutics","length":26,"tagName":"p"},{"type":"text","content":"At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.","length":666,"tagName":"p"},{"type":"text","content":"View source version on businesswire.com: https://www.businesswire.com/news/home/20260204548656/en/","length":98,"tagName":"p"},{"type":"text","content":"Contacts","length":8,"tagName":"p"},{"type":"text","content":"Investors:[email protected]","length":38,"tagName":...